dornase alfa
Showing 1 - 25 of 1,388
Multiple Trauma, Respiratory Distress Syndrome, Adult Trial in Strasbourg (Dornase Alfa Inhalant Solution [Pulmozyme], Placebos)
Recruiting
- Multiple Trauma
- Respiratory Distress Syndrome, Adult
- Dornase Alfa Inhalant Solution [Pulmozyme]
- Placebos
-
Strasbourg, FranceUniversity Hospital, Strasbourg, france
Jul 7, 2022
Ischemic Stroke Trial (Administration of dornase alfa)
Not yet recruiting
- Ischemic Stroke
- Administration of dornase alfa
- (no location specified)
Apr 21, 2022
COVID19, Hypoxia Trial in London (Dornase Alfa Inhalation Solution [Pulmozyme])
Completed
- COVID19
- Hypoxia
- Dornase Alfa Inhalation Solution [Pulmozyme]
-
London, United KingdomUniversity College London Hospital
Nov 8, 2021
COVID-19, Acute Respiratory Distress Syndrome Trial in Paris (Dornase Alfa Inhalation Solution [Pulmozyme], standard procedure)
Terminated
- COVID-19
- Acute Respiratory Distress Syndrome
- Dornase Alfa Inhalation Solution [Pulmozyme]
- standard procedure
-
Paris, FranceHôpital Fondation A. de Rotschhild
Dec 20, 2021
Ischemic Stroke, Inflammatory Response Trial in Munich (Dornase Alfa, Isotonic Saline Solution)
Not yet recruiting
- Ischemic Stroke
- Inflammatory Response
- Dornase Alfa
- Isotonic Saline Solution
-
Munich, Bavaria, GermanyInstitute for Stroke and Dementia Research, Ludwig Maximilian Un
Jun 1, 2023
SARS-CoV 2, ARDS Trial in Columbia (Dornase Alfa Inhalation Solution)
Completed
- SARS-CoV 2
- ARDS
- Dornase Alfa Inhalation Solution
-
Columbia, MissouriUniversity of Missouri Hospital and Clinics
Apr 12, 2021
COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml
Recruiting
- COVID-19 Severe Respiratory Failure
- Dexamethasone
- +5 more
-
Alexandroupolis, Evros, GreeceUniversity Hospital of Alexandroupolis
Mar 11, 2022
Loculated or Non-draining Malignant Pleural Effusions Trial in Philadelphia (Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND
Recruiting
- Loculated or Non-draining Malignant Pleural Effusions
- Combination TISSUE PLASMINOGEN ACTIVATOR (TPA) AND DORNASE ALFA (DNASE)
-
Philadelphia, PennsylvaniaEastern Regional Medical Center
Feb 10, 2021
Dornase Alfa Administered to Patients With COVID-19 (DACOVID)
Completed
- COVID-19
- Mechanical Ventilation
- Dornase Alfa
-
Manhasset, New YorkFeinstein Insitute for Medical Research at Northwell Health
Nov 12, 2020
COVID-19, Coronavirus Disease 2019 Trial in Moscow (Tigerase® and best available care, Best available care)
Completed
- COVID-19
- Coronavirus Disease 2019
- Tigerase® and best available care
- Best available care
-
Moscow, Russian Federation
- +5 more
Oct 13, 2020
Cystic Fibrosis, Fibrosis Trial in Russian Federation (Tigerase®, Pulmozyme®)
Completed
- Cystic Fibrosis
- Fibrosis
- Tigerase®
- Pulmozyme®
-
Barnaul, Altai Region, Russian Federation
- +13 more
Jul 8, 2020
Sjogren's Syndrome, Cough Trial in Farmington (Dornase alfa, Saline)
Withdrawn
- Sjogren's Syndrome
- Cough
- Dornase alfa
- Saline
-
Farmington, ConnecticutUniversity of CT Health Center
Jan 13, 2020
Lung Transplant Infection, Lower Respiratory Tract Infection Trial in Melbourne (Dornase Alfa, Isotonic Saline.)
Completed
- Lung Transplant Infection
- Lower Respiratory Tract Infection
- Dornase Alfa
- Isotonic Saline.
-
Melbourne, Victoria, AustraliaThe Alfred
Jul 22, 2019
Healthy Subjects Trial in Groningen (JHL1922, dornase alfa)
Completed
- Healthy Subjects
- JHL1922
- dornase alfa
-
Groningen, NetherlandsJHL Biotech Investigational Site
Jan 5, 2020
Qualitative Understanding of Experiences With the SIMPLIFY Trial
Recruiting
- Cystic Fibrosis
- Drug Withdrawal
- Qualitative Interview
-
Baltimore, Maryland
- +1 more
Mar 26, 2022
Pleural Empyema Trial in Canada (TPA (Tissue Plasminogen Activator), DNase, Placebo)
Completed
- Pleural Empyema
- TPA (Tissue Plasminogen Activator)
- +2 more
-
Calgary, Alberta, Canada
- +5 more
Apr 6, 2020
Non-cystic Fibrosis Bronchiectasis Trial in United States (ARINA-1, Placebo)
Not yet recruiting
- Non-cystic Fibrosis Bronchiectasis
- ARINA-1
- Placebo
-
Birmingham, Alabama
- +8 more
Aug 10, 2022
Cystic Fibrosis, Mucociliary Clearance Defect Trial in Iowa City, Columbia (Symptom driven performance of airway clearance,
Not yet recruiting
- Cystic Fibrosis
- Mucociliary Clearance Defect
- Symptom driven performance of airway clearance
- Continuous daily performance of airway clearance
-
Columbia, MissouriUniversity of Missouri Hospital and Clinics
Dec 12, 2022
Hypophosphatasia Trial in Worldwide (ALXN1850, asfotase alfa)
Not yet recruiting
- Hypophosphatasia
- ALXN1850
- asfotase alfa
-
Hartford, Connecticut
- +29 more
Oct 6, 2023
Hypophosphatasia Trial in Würzburg (Ilofotase Alfa, 0.8 mg/kg, Ilofotase Alfa, 3.2 mg/kg)
Recruiting
- Hypophosphatasia
- Ilofotase Alfa, 0.8 mg/kg
- Ilofotase Alfa, 3.2 mg/kg
-
Würzburg, GermanyOsteologie / Klinische Studieneinheit, Orthopädische Klinik - KL
May 26, 2023
Outcomes in Hospitalised Patients Treated With Ondexxya
Not yet recruiting
- Hemorrhage
- Andexanet alfa
- (no location specified)
Jun 12, 2023